4//SEC Filing
Lee Ann 4
Accession 0001493152-23-000226
CIK 0001835022other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:30 AM ET
Size
11.0 KB
Accession
0001493152-23-000226
Insider Transaction Report
Form 4
Lee Ann
Director
Transactions
- Conversion
Common Stock, par value $0.0001 per share
2023-01-03$4.00/sh+6,479$25,916→ 16,479 total - Purchase
Common Stock, par value $0.0001 per share
2023-01-03+10,000→ 10,000 total - Purchase
Warrant to Purchase Common Stock
2023-01-03+5,000→ 9,479 totalExercise: $7.50From: 2023-01-03Exp: 2025-01-03→ Common Stock, par value $0.0001 per share (5,000 underlying) - Conversion
6% Convertible Note
2023-01-03→ 6,479 totalExercise: $4.00→ Common Stock, par value $0.0001 per share (6,479 underlying)
Footnotes (2)
- [F1]Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering ("IPO") at a combined purchase price $5.00 per share and accompanying warrant.
- [F2]Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum.
Documents
Issuer
Coya Therapeutics, Inc.
CIK 0001835022
Entity typeother
Related Parties
1- filerCIK 0001953080
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 8:30 AM ET
- Size
- 11.0 KB